The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study
Abstract
AIM: Our goal was to develop an efficient nanoparticle-based system that can overcome the restrictive mechanism of the blood-brain barrier (BBB) by targeting insulin receptors and would thus enable drug delivery to the brain. METHODS: Insulin-coated gold nanoparticles (INS-GNPs) were synthesized to serve as a BBB transport system. The effect of nanoparticle size (20, 50 and 70 nm) on their ability to cross the BBB was quantitatively investigated in Balb/C mice. RESULTS: The most widespread biodistribution and highest accumulation within the brain were observed using 20 nm INS-GNPs, 2 h post injection. In vivo CT imaging revealed that particles migrated to specific brain regions, which are involved in neurodegenerative and neuropsychiatric disorders. CONCLUSION: These findings promote the optimization of nanovehicles for transport of drugs through the BBB. The insulin coating of the particles enabled targeting of specific brain regions, suggesting the potential use of INS-GNPs for delivery of various treatments for brain-related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,615
Mechanics of receptor-mediated endocytosis
Gao, H., Shi, W., & Freund, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503879102 · Cited by 1,217
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Silica Particles: A Novel Drug‐Delivery System
Barbé, C., Bartlett, J., Kong, L., Finnie, K., Lin, H. Q., Larkin, M., Calleja, S., Bush, A., & Calleja, G. (2004) · Advanced Materials · doi:10.1002/adma.200400771 · Cited by 859
Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer
Popovtzer, R., Agrawal, A., Kotov, N. A., Popovtzer, A., Balter, J., Carey, T. E., & Kopelman, R. (2008) · Nano Letters · doi:10.1021/nl8029114 · Cited by 801
Self-citationTransport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
Deli, M. A., Ábrahám, C. S., Kataoka, Y., & Niwa, M. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1377-8 · Cited by 643
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Series Introduction: Neurodegeneration: What is it and where are we?
Przedborski, S., Vila, M., & Jackson-Lewis, V. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17522 · Cited by 584
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 565
Zhang, G., Yang, Z., Lu, W., Zhang, R., Huang, Q., Tian, M., Li, L., Liang, D., & Li, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.038 · Cited by 563
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Gold nanoparticles: opportunities and challenges in nanomedicine
Arvizo, R., Bhattacharya, R., & Mukherjee, P. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003777010 · Cited by 538
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
Development of the blood-brain barrier
Engelhardt, B. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0751-z · Cited by 379
Insulin and the Blood-Brain Barrier
Woods, S., Seeley, R., Baskin, D., & Schwartz, M. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455323 · Cited by 320
Gao, K., & Jiang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.040 · Cited by 269
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Brown, R. S., Leung, J. Y., Kison, P. V., Zasadny, K. R., Flint, A., & Wahl, R. L. (1999) · PubMed · Cited by 247
Meir, R., Shamalov, K., Betzer, O., Motiei, M., Horovitz-Fried, M., Yehuda, R., Popovtzer, A., Popovtzer, R., & Cohen, C. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01939 · Cited by 239
Self-citationShilo, M., Sharon, A., Baranes, K., Motiei, M., Lellouche, J.-P. M., & Popovtzer, R. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0075-7 · Cited by 237
Self-citationReengineering Biopharmaceuticals for Targeted Delivery Across the Blood–Brain Barrier
Pardridge, W. M., & Boado, R. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00011-2 · Cited by 199
Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
Shilo, M., Motiei, M., Hana, P., & Popovtzer, R. (2014) · Nanoscale · doi:10.1039/c3nr04878k · Cited by 193
Self-citationGiudice, C. L., Herda, L. M., Polo, E., & Dawson, K. A. (2016) · Nature Communications · doi:10.1038/ncomms13475 · Cited by 167
In Vivo Methods to Study Uptake of Nanoparticles into the Brain
van Rooy, I., Cakir-Tascioglu, S., Hennink, W. E., Storm, G., Schiffelers, R. M., & Mastrobattista, E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0291-7 · Cited by 150
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes
Afergan, E., Epstein-Barash, H., Dahan, R., Koroukhov, N., Rohekar, K., Danenberg, H. D., & Golomb, G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.017 · Cited by 136
Voigt, N., Henrich‐Noack, P., Kockentiedt, S., Hintz, W., Tomas, J., & Sabel, B. A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.013 · Cited by 130
Imaging Approach to Mechanistic Study of Nanoparticle Interactions with the Blood–Brain Barrier
Bramini, M., Dong, Y., Hallerbach, A., Raghnaill, M. N., Salvati, A. L., Åberg, C., & Dawson, K. A. (2014) · ACS Nano · doi:10.1021/nn5018523 · Cited by 128
Measurement of cerebral blood volume in mouse brain regions using micro-computed tomography
Chugh, B. P., Lerch, J. P., Yu, L. X., Pienkowski, M., Harrison, R. V., Henkelman, R. M., & Sled, J. G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.083 · Cited by 121
Popovtzer, A., Mizrachi, A., Motiei, M., Bragilovski, D., Lubimov, L., Levi, M., Hilly, O., Ben‐Aharon, I., & Popovtzer, R. (2016) · Nanoscale · doi:10.1039/c5nr07496g · Cited by 111
Self-citationBetzer, O., Shwartz, A., Motiei, M., Kazimirsky, G., Gispan, I. H., Damti, E., Brodie, C., Yadid, G., & Popovtzer, R. (2014) · ACS Nano · doi:10.1021/nn503131h · Cited by 110
Self-citation3D micro-CT imaging of the postmortem brain
de Crespigny, A. J., Bou-Reslan, H., Nishimura, M. C., PHILLIPS, H. S., Carano, R. A. D., & D'Arceuil, H. E. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.03.006 · Cited by 103
Linking Essential Tremor to the Cerebellum—Neuroimaging Evidence
Cerasa, A., & Quattrone, A. (2015) · The Cerebellum · doi:10.1007/s12311-015-0739-8 · Cited by 101
Mapping of Molecular Structure of the Nanoscale Surface in Bionanoparticles
Herda, L. M., Hristov, D. R., Lo Giudice, M. C., Polo, E., & Dawson, K. A. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12297 · Cited by 100
Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model
Glazer, E. S., Zhu, C., Hamir, A. N., Borne, A. T., Thompson, C. S., & Curley, S. A. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.516026 · Cited by 83
A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss, T., Betzer, O., Shilo, M., Popovtzer, A., Motiei, M., & Popovtzer, R. (2015) · Nanoscale · doi:10.1039/c5nr03119b · Cited by 83
Self-citationIn-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications
Betzer, O., Meir, R., Dreifuss, T., Shamalov, K., Motiei, M., Shwartz, A., Baranes, K., Cohen, C. J., Shraga‐Heled, N., Ofir, R., et al. (2015) · Scientific Reports · doi:10.1038/srep15400 · Cited by 78
Self-citationMeir, R., Betzer, O., Motiei, M., Kronfeld, N., Brodie, C., & Popovtzer, R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.09.013 · Cited by 61
Self-citationShilo, M., Berenstein, P., Dreifuss, T., Nash, Y., Goldsmith, G., Kazimirsky, G., Motiei, M., Frenkel, D., Brodie, C., & Popovtzer, R. (2015) · Nanoscale · doi:10.1039/c5nr04881h · Cited by 55
Self-citationAn ultra-sensitive dual-mode imaging system using metal-enhanced fluorescence in solid phantoms
Barnoy, E. A., Fixler, D., Popovtzer, R., Nayhoz, T., & Ray, K. (2015) · Nano Research · doi:10.1007/s12274-015-0891-y · Cited by 54
Self-citationEffect of Gold Nanoparticle Size and Coating on Labeling Monocytes for CT Tracking
Chhour, P., Kim, J., Benardo, B., Tovar, A., Mian, S., Litt, H. I., Ferrari, V. A., & Cormode, D. P. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00566 · Cited by 54
Betzer, O., Ankri, R., Motiei, M., & Popovtzer, R. (2015) · Journal of Nanomaterials · doi:10.1155/2015/646713 · Cited by 51
Self-citationRempe, R. G., Cramer, S., Qiao, R., & Galla, H. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1819-7 · Cited by 38
Seeing the Light: Insulin Receptors and the CNS
Needleman, L. A., & McAllister, A. K. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.001 · Cited by 16
Biomedical Applications of Gold Nanomaterials
Popovtzer, R. (2014) · Nanomedicine · doi:10.2217/nnm.14.151 · Cited by 13
Self-citation
Cited by
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Hersh, A. M., Alomari, S., & Tyler, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084153 · Cited by 478
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
Guo, S., Perets, N., Betzer, O., Ben-Shaul, S., Sheinin, A., Michaelevski, I., Popovtzer, R., Offen, D., & Levenberg, S. (2019) · ACS Nano · doi:10.1021/acsnano.9b01892 · Cited by 424
Self-citationDrug delivery to the central nervous system
Nance, E., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 414
Metadata
- Authors
- Betzer, O., Shilo, M., Opochinsky, R., Barnoy, E., Motiei, M., Okun, E., Yadid, G., & Popovtzer, R.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-06-16
- Volume
- 12
- Issue
- 13
- Pages
- 1533-1546
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2626315766
- Cited by
- 301
- References
- 52
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.